407 results on '"Cummings, F."'
Search Results
2. The effects of the thickness of the sandwiched layer and of the annealing time on induced nanostructures during solid state dewetting of a metal-semiconductor-substrate triple layer structure
3. P359 Persistence of severe fatigue in adults with Crohn's disease in remission
4. P128 Salt-Inducible Kinase 2 is a promising therapeutic target in patients with ulcerative colitis
5. P873 Ustekinumab Real World Evidence Study (UndieS): Assessing the suitability of patients treated in routine clinical care for participation in the pivotal phase 3 clinical trial
6. P069 Ultra-processed food intake and dietary insufficiencies are common in adults with Crohn’s Disease in remission. The INTICO 2 Study
7. P875 Filgotinib in ulcerative colitis: early real-world multicentre UK experience
8. P1015 Subcutaneous infliximab effectively manages clinical outcomes of Inflammatory Bowel Disease independently of various confounding factors
9. P984 VEST: The UK vedolizumab real life experience study in Inflammatory Bowel Disease
10. P712 Effectiveness of switching from intravenous to subcutaneous infliximab in Inflammatory Bowel Disease patients: A combined analysis of real-world evidence
11. Stimulated Emission of Radiation in a Single Mode for both Resonance and Non-resonance for Various Initial Photon Distributions
12. Annealing effects on elemental composition and morphological properties of Pd thin films grown on crystalline silicon substrate
13. Cross-sectional transmission electron microscopy studies of boron ion implantation in hexagonal boron nitride
14. Phyllotaxis, a model
15. Seasonal abundances of euthecosomatous pteropods and heteropods from waters overlying San Pedro Basin, California
16. Quantum Entangled Supercorrelated States in the Jaynes-Cummings Model
17. P660 Body composition and health-related quality of life in adult Crohn’s Disease during clinical remission: The INTICO2 cohort study
18. P400 Identifying Nutritional targets in Crohn’s disease: INTICO1: a time-limited trial of exclusive enteral nutrition during adult CD remission
19. P498 Ustekinumab Real World Evidence Study (UndieS): study design with information about positioning and the choice of ustekinumab
20. P389 Switching infliximab to subcutaneous from intravenous therapy (SWIMSUIT) – A prospective, real-world, single centre, phase IV interventional study
21. Establishing key performance indicators for inflammatory bowel disease in the UK
22. A highly responsive NH3 sensor based on Pd-loaded ZnO nanoparticles prepared via a chemical precipitation approach
23. Proton-induced nanorod melting in a coating obtained from the pulsed laser ablation of [formula omitted]
24. The effect of hydrothermal grown zinc oxide nanoparticles as seeds on the properties of nanoripples in zinc oxide thin films
25. PWE-053 Development of data linkage techniques to support the uk ibd registry: making the most of routine nhs datasets
26. The Northern Pacific Case
27. Social Surveys as a Basis of Instruction
28. P585 IBD Reference and Biosimilar adalimumab CroSS over Study (iBaSS): a mixed methods clinical trial of patients transitioning between originator and biosimilar adalimumab. Qualitative findings from an interim analysis presenting the patient perspective
29. OC-001 anti-TNF Withdrawal in IBD: Initial Results from a Pan-UK Study
30. O18 IBD care in 2020: results from the first IBD UK patient and service benchmarking tool
31. Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
32. EFFICACY OF HIGH AND LOW DOSE ORAL VITAMIN D REPLACEMENT THERAPY IN INFLAMMATORY BOWEL DISEASE (IBD): SINGLE CENTRE COHORT
33. OC-162 The role of micrornas MIR-31 AND MIR-155 in the deregulation of the IL-13 pathway in ulcerative colitis
34. P616 IBD reference and biosimilar adalimumab CroSS over study (iBaSS): design considerations and methodology
35. The pattern and outcome of acute severe colitis
36. Role of participation in the evaluation and implementation of development projects
37. Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization and impact in ulcerative Colitis)
38. That giant sucking sound: the consequences of short-sighted rate making
39. Introduction
40. P384 High incidence of hyperglycaemia in steroid treated hospitalised inflammatory bowel disease (IBD) patients and its risk factors identified by machine learning methods
41. Clinical pharmacokinetics of 3-day continuous infusion cisplatin and daily bolus 5-Fluorouracil
42. Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial
43. Polarization Modulation in Ferroelectric Organic Field-Effect Transistors
44. Some Tests of the Factor-Supplier Pressure Group Hypothesis
45. On Morphogenesis in Living Systems
46. Th17 cells expressing KIR3DL2 and enriched for gut homing markers are increased in ankylosing spondylitis
47. Ustekinumab as induction and maintenance therapy for Crohn's disease
48. Aspects of Condensation in 4He II
49. Genome-wide and fine-resolution association analysis of malaria in West Africa
50. AODTH-005 Transcriptomic profiling of intestinal macrophages isolated from patients reveals a profound gene expression reprogramming underlying ibd pathogenesis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.